Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"
NCT05872009 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2023-05-23
Summary
The GaP study is designed to close important knowledge gaps by:
1. exploring placental health and cellular ageing in GDM and the association with neonatal outcome
2. evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM
Conditions
- Gestational Diabetes
- Cardiovascular Diseases
- Placenta Diseases
Sponsors & Collaborators
-
Norwegian SIDS and Stillbirth Society
collaborator OTHER -
Oslo University Hospital
lead OTHER
Principal Investigators
-
Meryam Sugulle, PhD · Oslo University Hospital, Division of Gynaecology and Obstetrics, Ullevål
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- Norway
Study Locations
More Related Trials
-
Gestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring
NCT01490372 ·Status: COMPLETED
-
Metabolic and Endocrine Status in Women With Prior Preterm Birth
NCT01355536 ·Status: COMPLETED
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Maternal and Fetal Metabolic Changes
NCT06288126 ·Status: COMPLETED
-
The Use of the CPR to Predict Adverse Outcomes in GDM Pregnancies
NCT03072563 ·Status: UNKNOWN
-
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
NCT02564250 ·Status: UNKNOWN
-
Lifestyle Intervention for Women With Recent Pre-eclampsia or Gestational Diabetes Mellitus ('Mom's Healthy Heart')
NCT03993145 ·Status: COMPLETED ·Phase: NA
-
Pregnancy Cohort Study: Pregnancy as a Window to Future Health
NCT06925815 ·Status: RECRUITING
-
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
NCT03570632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Glycated Albumin in Pregnancy
NCT03372824 ·Status: COMPLETED
-
Characterization and Epigenetics of Post-Partum Preeclampsia
NCT02935556 ·Status: TERMINATED
-
Prognosis of Extremely Premature Birth
NCT01150396 ·Status: UNKNOWN
-
The Use of Early Pregnancy HbA1c in Predicting Excessive Fetal Growth in Women at Risk of Glucose Intolerance
NCT04858386 ·Status: TERMINATED
-
Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)
NCT02211651 ·Status: COMPLETED
-
Possible Epigenetic Changes in Offspring of Women With Pregestational and Gestational Diabetes
NCT01255384 ·Status: UNKNOWN
-
A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia
NCT00403572 ·Status: COMPLETED
-
Gestational Diabetes - PrEvention of PostPartum Diabetes Study
NCT05112588 ·Status: RECRUITING ·Phase: NA
-
Fetus Programming and Long Active Outcomes, Interaction Between Mother, Placenta and Fetus in Perinatal and Methabolic Disbalansces-focusing Diabetic Pregnancies
NCT07337759 ·Status: COMPLETED
-
Innovations in Placental Metabolism and Association With Antioxidants and Nutrients in Diabetes and Gestational Obesity
NCT05174728 ·Status: SUSPENDED
-
Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids
NCT03738293 ·Status: WITHDRAWN
-
The Belgian Diabetes in Pregnancy Follow-up Study
NCT04429958 ·Status: COMPLETED
-
Fetal Growth and Pregnancy Complications Among Women With Heart Disease
NCT03657823 ·Status: UNKNOWN
-
New Biomarkers Associated With the Risk of Premature Delivery.
NCT04067908 ·Status: COMPLETED ·Phase: NA
-
Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus
NCT05019508 ·Status: COMPLETED
-
Venous Thromboembolism in Pregnancy Study
NCT00856076 ·Status: UNKNOWN